WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010026467) CONTROLLED RELEASE TABLET OF A HIGHLY WATER SOLUBLE ACTIVE AGENT SUCH AS LEVETIRACETAM, OR CITICOLINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/026467    International Application No.:    PCT/IB2009/006733
Publication Date: 11.03.2010 International Filing Date: 03.09.2009
IPC:
A61K 9/20 (2006.01)
Applicants: TORRENT PHARMACEUTICALS LTD. [IN/IN]; Torrent House, Off Ashram Road Near Dinesh Hall Gujarat Ahmedabad 380 009 (IN) (For All Designated States Except US).
ABRAHAM, Jaya [IN/IN]; (IN) (For US Only).
GUPTA, Vinodkumar [IN/IN]; (IN) (For US Only).
SHAH, Bhavesh [IN/IN]; (IN) (For US Only)
Inventors: ABRAHAM, Jaya; (IN).
GUPTA, Vinodkumar; (IN).
SHAH, Bhavesh; (IN)
Agent: SUBRAMANIAM, Hariharan; Subramaniam, Nataraj & Associates E-556, Greater Kailash-II New Delhi, 110-048 (IN)
Priority Data:
1868/MUM/2008 04.09.2008 IN
Title (EN) CONTROLLED RELEASE TABLET OF A HIGHLY WATER SOLUBLE ACTIVE AGENT SUCH AS LEVETIRACETAM, OR CITICOLINE
(FR) FORME PHARMACEUTIQUE À LIBÉRATION PROLONGÉE DE PRINCIPE ACTIF HAUTEMENT SOLUBLE
Abstract: front page image
(EN)The present invention relates to a solid oral controlled release dosage form comprising high solubility active ingredient, wherein the dosage form is manufactured by single step granulation using at least one hydrophobic release controlling agent. The said dosage form is further coated using at least one hydrophobic release controlling agent. The present invention further discloses the process for preparing the said dosage form. Preferred water soluble drugs are levetiracetam or citicoline.
(FR)La présente invention concerne une forme pharmaceutique orale solide à libération prolongée comprenant un principe actif hautement soluble, la forme pharmaceutique étant fabriquée par granulation en une seule opération au moyen d'au moins un régulateur de libération hydrophobe. Cette forme pharmaceutique est en outre enrobée au moyen d'au moins un régulateur de libération hydrophobe. L'invention concerne également le procédé d'élaboration de ladite forme pharmaceutique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)